Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ruiz-Gabarre

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Diseases (Basel, Switzerland)|January 30, 2019
Modulating Effect of Diet on Alzheimer's DiseasePaloma Fernández-Sanz, Daniel Ruiz-Gabarre, Vega García-Escudero
Antioxidants (Basel, Switzerland)|July 29, 2023
Alzheimer's Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative StressVíctor Valverde-Salazar, Daniel Ruiz-Gabarre, Vega García-Escudero
Cells|March 10, 2022
What's in a Gene? The Outstanding Diversity of <i>MAPT</i>Daniel Ruiz-Gabarre, Almudena Carnero-Espejo, Jesús Ávila, et al.
ACS Chemical Neuroscience|June 13, 2022
Specific Peptide from the Novel W-Tau Isoform Inhibits Tau and Amyloid β Peptide Aggregation <i>In Vitro</i>Raquel Cuadros, Mar Pérez, Daniel Ruiz-Gabarre, et al.
Journal of Alzheimer'S Disease Reports|December 12, 2022
Mouse and Human Tau Expression in Different Brain AreasLaura Vallés-Saiz, Daniel Ruiz-Gabarre, Vega García-Escudero, et al.
Ebiomedicine|January 5, 2024
Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3Daniel Ruiz-Gabarre, Laura Vallés-Saiz, Almudena Carnero-Espejo, et al.
Acta Neuropathologica|May 2, 2021
A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's diseaseVega García-Escudero, Daniel Ruiz-Gabarre, Ricardo Gargini, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Diseases (Basel, Switzerland)|January 30, 2019
Modulating Effect of Diet on Alzheimer's DiseasePaloma Fernández-Sanz, Daniel Ruiz-Gabarre, Vega García-Escudero
Antioxidants (Basel, Switzerland)|July 29, 2023
Alzheimer's Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative StressVíctor Valverde-Salazar, Daniel Ruiz-Gabarre, Vega García-Escudero
Cells|March 10, 2022
What's in a Gene? The Outstanding Diversity of <i>MAPT</i>Daniel Ruiz-Gabarre, Almudena Carnero-Espejo, Jesús Ávila, et al.
ACS Chemical Neuroscience|June 13, 2022
Specific Peptide from the Novel W-Tau Isoform Inhibits Tau and Amyloid β Peptide Aggregation <i>In Vitro</i>Raquel Cuadros, Mar Pérez, Daniel Ruiz-Gabarre, et al.
Journal of Alzheimer'S Disease Reports|December 12, 2022
Mouse and Human Tau Expression in Different Brain AreasLaura Vallés-Saiz, Daniel Ruiz-Gabarre, Vega García-Escudero, et al.
Ebiomedicine|January 5, 2024
Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3Daniel Ruiz-Gabarre, Laura Vallés-Saiz, Almudena Carnero-Espejo, et al.
Acta Neuropathologica|May 2, 2021
A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's diseaseVega García-Escudero, Daniel Ruiz-Gabarre, Ricardo Gargini, et al.
Pageof 1